Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period.

Marcus GM, Smith LM, Whiteman D, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE.

Pacing Clin Electrophysiol. 2008 Mar;31(3):266-72. doi: 10.1111/j.1540-8159.2008.00985.x.

PMID:
18307620
2.

Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.

Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K.

J Heart Lung Transplant. 2006 Jan;25(1):53-60. Epub 2005 Nov 2.

PMID:
16399531
3.

Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.

Dasari TW, Pavlovic-Surjancev B, Patel N, Williams AA, Ezidinma P, Rupani A, Sinacore JL, Heroux AL.

Am J Cardiol. 2010 Sep 1;106(5):737-41. doi: 10.1016/j.amjcard.2010.04.035. Epub 2010 Jul 23.

PMID:
20723655
4.

Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A; ALLHAT Collaborative Research Group.

J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. doi: 10.1016/j.jacc.2009.08.020.

5.

Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.

Luria DM, Hodge DO, Monahan KH, Haroldson JM, Shen WK, Asirvatham SJ, Hammill SC, Munger TM, Glikson M, Gersh BJ, Packer DL, Friedman PA.

J Cardiovasc Electrophysiol. 2008 Nov;19(11):1145-50. doi: 10.1111/j.1540-8167.2008.01206.x. Epub 2008 May 19.

PMID:
18554204
6.

Dissociation between coronary sinus and left atrial conduction in patients with atrial fibrillation and flutter.

Ndrepepa G, Zrenner B, Schneider MA, Schreieck J, Karch MR, Schömig A, Schmitt C.

J Cardiovasc Electrophysiol. 2001 Jun;12(6):623-8.

PMID:
11405392
7.

Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.

Peyrol M, Sbragia P, Bonello L, Lévy S, Paganelli F.

Arch Cardiovasc Dis. 2011 Oct;104(10):530-5. doi: 10.1016/j.acvd.2011.07.003. Epub 2011 Oct 14.

8.

Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance.

Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R, Wolpert C, Becher H, Lüderitz B, Omran H.

J Am Coll Cardiol. 2001 Sep;38(3):778-84.

9.

Increased incidence of atrial flutter associated with the rejection of heart transplantation.

Cui G, Tung T, Kobashigawa J, Laks H, Sen L.

Am J Cardiol. 2001 Aug 1;88(3):280-4.

PMID:
11472708
10.

Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.

Amin AN, Jhaveri M, Lin J.

Adv Ther. 2011 Oct;28(10):907-26. doi: 10.1007/s12325-011-0065-6. Epub 2011 Sep 30.

PMID:
21971681
11.

Atrial flutter ablation in inducible patients during pulmonary vein atrum isolation: a randomized comparison.

Schmidt M, Daccarett M, Segerson N, Airey KJ, Günther J, Marschang H, Fish E, Rittger H, Sinha AM, Ritscher G, Brachmann J, Marrouche NF.

Pacing Clin Electrophysiol. 2008 Dec;31(12):1592-7. doi: 10.1111/j.1540-8159.2008.01231.x.

PMID:
19067812
12.

Electrophysiological response of the right atrium to ibutilide during typical atrial flutter.

Cheng J, Glatter K, Yang Y, Zhang S, Lee R, Scheinman MM.

Circulation. 2002 Aug 13;106(7):814-9.

13.

Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy.

Bhavnani SP, Coleman CI, White CM, Clyne CA, Yarlagadda R, Guertin D, Kluger J.

Europace. 2008 Jul;10(7):854-9. doi: 10.1093/europace/eun128. Epub 2008 May 20.

PMID:
18495672
14.

Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy.

Brembilla-Perrot B, Schwartz J, Huttin O, Frikha Z, Sellal JM, Sadoul N, Blangy H, Olivier A, Louis S, Kaminsky P.

Pacing Clin Electrophysiol. 2014 Mar;37(3):329-35. doi: 10.1111/pace.12260. Epub 2013 Oct 9.

PMID:
24117873
15.

Increasing prevalence of atrial fibrillation and flutter in the United States.

Naccarelli GV, Varker H, Lin J, Schulman KL.

Am J Cardiol. 2009 Dec 1;104(11):1534-9. doi: 10.1016/j.amjcard.2009.07.022.

PMID:
19932788
16.

Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.

Oliveira MM, da Silva N, Timóteo AT, Feliciano J, de Sousa L, Santos S, Marques F, Ferreira R.

Rev Port Cardiol. 2007 Jul-Aug;26(7-8):691-702. English, Portuguese.

17.

Prolonged fractionation of paced right atrial electrograms in patients with atrial flutter and fibrillation.

Tai CT, Chen SA, Tzeng JW, Kuo BI, Ding YA, Chang MS, Shyu LY.

J Am Coll Cardiol. 2001 May;37(6):1651-7.

18.
19.

The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.

Rossman EI, Liu K, Morgan GA, Swillo RE, Krueger JA, Gardell SJ, Butera J, Gruver M, Kantrowitz J, Feldman HS, Petersen JS, Haugan K, Hennan JK.

J Pharmacol Exp Ther. 2009 Jun;329(3):1127-33. doi: 10.1124/jpet.108.150102. Epub 2009 Feb 27.

20.

Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.

Kawabata M, Hirao K, Higuchi K, Sasaki T, Furukawa T, Okada H, Hachiya H, Isobe M.

Europace. 2008 Mar;10(3):284-8. doi: 10.1093/europace/eun012. Epub 2008 Feb 7.

PMID:
18258806

Supplemental Content

Support Center